HEALTHCO HEALTHCARE & WELLNESS REIT (HCW)
Share Price Analysis and Chart

Enter the company code or Name for stock analysis:

HCW

HCW - HEALTHCO HEALTHCARE & WELLNESS REIT

FNArena Sector : REITs
Year End: June
GICS Industry Group : Real Estate
Debt/EBITDA: 12.42
Index: ALL-ORDS

LAST PRICE CHANGE +/- CHANGE % VOLUME

$0.705

25 Jun
2026

-0.010

OPEN

$0.71

-1.40%

HIGH

$0.71

1,090,751

LOW

$0.69

TARGET
$0.793

-0.04 change from previous day

12.5% upside
OTHER COMPANIES IN THE SAME SECTOR
ABG . ARF . ASK . BWP . CDP . CDP . CHC . CIP . CLW . COF . CQE . CQR . DGT . DXC . DXI . DXS . GDF . GDI . HDN . PLG . REP . RFF . RGN . SCG . VCX . WOT . WPR .
FNARENA'S MARKET CONSENSUS FORECASTS
HCW: 1
Title FY25
Actual
FY26
Actual
FY27
Forecast
FY28
Forecast
EPS (cps) xxx - 9.0 5.2 xxx
DPS (cps) xxx 0.0 5.7 xxx
EPS Growth xxx N/A N/A xxx
DPS Growth xxx N/A N/A xxx
PE Ratio xxx N/A 14.6 xxx
Dividend Yield xxx N/A 7.5% xxx
Div Pay Ratio(%) xxx N/A 109.6% xxx

Dividend yield today if purchased 3 years ago: 0.00%

DIVIDEND YIELD CALCULATOR

Dividend Yield Today On Last Actual Payout :

0.00

Estimated Dividend Growth
(Average Of Past Three Years)

 %

Amount Invested

Tell Me The Dividend After This Many Years

Past performance is no guarantee for the future. Investors should take into account that heavy swings in share price or exceptional circumstances (a la 2009) can have a significant impact on short term calculations and averages

Last ex-div: 30/12 - (franking ex-div 2.10c)

HISTORICAL DATA ARE ALL IN AUD
Copyright © 2026 FactSet UK Limited. All rights reserved
Title 2023202420252026
EPS Basic xxxxxxxxx-9.0
DPS All xxxxxxxxx0.0
Sales/Revenue xxxxxxxxx59.0 M
Book Value Per Share xxxxxxxxx134.2
Net Operating Cash Flow xxxxxxxxx18.0 M
Net Profit Margin xxxxxxxxx-84.24 %

EPS Basic

DPS All

Sales/Revenue

Book Value Per Share

Net Operating Cash Flow

Net Profit Margin

Title 2023202420252026
Return on Capital Employed xxxxxxxxx-6.51 %
Return on Invested Capital xxxxxxxxx-6.49 %
Return on Assets xxxxxxxxx-4.10 %
Return on Equity xxxxxxxxx-6.51 %
Return on Total Capital xxxxxxxxx3.73 %
Free Cash Flow ex dividends xxxxxxxxx18.0 M

Return on Capital Employed

Return on Invested Capital

Return on Assets

Return on Equity

Return on Total Capital

Free Cash Flow ex dividends

Title 2023202420252026
Short-Term Debt xxxxxxxxx372 M
Long Term Debt xxxxxxxxx3 M
Total Debt xxxxxxxxx375 M
Goodwill - Gross xxxxxxxxx-
Cash & Equivalents - Generic xxxxxxxxx56 M
Price To Book Value xxxxxxxxx0.53

Short-Term Debt

Long Term Debt

Total Debt

Goodwill - Gross

Cash & Equivalents - Generic

Price To Book Value

Title 2023202420252026
Capex xxxxxxxxx0.0 M
Capex % of Sales xxxxxxxxx0.00 %
Cost of Goods Sold xxxxxxxxx13 M
Selling, General & Admin. Exp & Other xxxxxxxxx2 M
Research & Development xxxxxxxxx-
Investments - Total xxxxxxxxx772 M

Capex

Capex % of Sales

Cost of Goods Sold

Selling, General & Admin. Exp & Other

Research & Development

Investments - Total

EXPERT VIEWS
Display All Commentary

Sentiment Indicator

0.5

No. Of Recommendations

2
BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Macquarie

xx/xx/xxxx

1

xxxxxxx xx xxxxxxxxxx xxxx xxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Morgan Stanley

29/05/2026

5

Underweight

$0.70

-0.71%

Morgan Stanley believes HealthCo Healthcare & Wellness REIT's announcement of a new operator for Mount Hospital as a positive step toward resolving the ongoing Healthscope lease uncertainty.

The lease will transfer to Bethesda Health Care, backed by a Western Australian government guarantee, with the new agreement commencing during 1QFY27.

While face rent remains unchanged, incentives attached to the lease are expected to reduce the asset valuation by -10%-15%.

Morgan Stanley notes uncertainty remains around the remaining Healthscope leases and cautions distributions could remain under pressure.

Unchanged Underweight rating and 70c target. Industry view: In-Line.

FORECAST
Morgan Stanley forecasts a full year FY26 dividend of 0.00 cents and EPS of 4.00 cents.
Morgan Stanley forecasts a full year FY27 dividend of 6.00 cents and EPS of 7.00 cents.

EXTRA COVERAGE
Display All Commentary

No. Of Recommendations

0

Please note: unlike Broker Call Report, BC Extra is not updated daily. The info you see might not be the latest. FNArena does its best to update ASAP.

BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

HCW STOCK CHART